Key Studies Influencing My Practice Following 2019 Fall HIV Conferences

Source: 2019 IDWeek, the Co-morbidities and Adverse Drug Reactions Workshop, and the European AIDS Conference*
Download Audio
IDWeek 2019; October 2-6, 2019; Washington, DC
21st International Workshop on Co-morbidities and Adverse Drug Reactions in HIV; November 5-6, 2019; Basel, Switzerland
17th European AIDS Conference; November 6-9, 2019; Basel, Switzerland
Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on the most clinically relevant new HIV data presented at 3 recent conferences, including data on HIV prevention, first-line and switch strategies, and weight gain during ART.
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Format: Audio (.mp3)
File Size: 11.7 MB
Released: November 21, 2019

Acknowledgements

Provided by USF Health
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Understand medical, social, and emotional challenges faced by older PWH, from Clinical Care Options (CCO)

Jonathan Appelbaum, MD, FACP, AAHIVS
Program Director Melanie Reese
Program Director Lydia Mungherera, MBChB Cristina Mussini, MD Dorothy Onyango Marc Thompson Released: August 9, 2022

HIV self-testing and 6-month PrEP dispensing simplified PrEP delivery with no reduction in HIV testing or PrEP adherence, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 5, 2022

ANDES: Wk 48 safety and efficacy of generic darunavir/ritonavir + lamivudine for initial HIV treatment, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 5, 2022

Efficacy of doxycycline PEP for prevention of STIs in MSM and TGW in the DoxyPEP study, reported by Clinical Care Options (CCO) from AIDS 2022

Released: August 4, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings